AACR Showcases Early Cancer Drugs, Early Use Of Biomarker Strategies
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
At the American Association for Cancer Research annual meeting in Chicago, data were presented on early-stage projects, some of them for the first time, as AACR displayed its growing enthusiasm for translational medicine.